Health Secretary Robert F. Kennedy Jr., who focused heavily on vaccine policy in 2025, will spend this year talking up ...
The F.D.A.’s refusal to examine the company’s mRNA shot drew widespread criticism from doctors and was divisive within the ...
Regulators move the goalposts for a manufacturer that uses mRNA technology.
America’s drug safety agency declined to review a next-gen flu vaccine that uses the same tech as the coronavirus shots ...
Moderna said the move is inconsistent with previous feedback from the FDA on the experimental influenza shot, called ...
In the early 1960s, after studies confirmed that it was linked to congenital disorders in more than 10,000 children, ...
12hon MSN
Novo Nordisk CEO sees 15 million patient opportunity in Medicare coverage for obesity drugs
Doustdar said Medicare coverage and the launch of Novo's new obesity pill should help gradually boost prescription volumes ...
The Food and Drug Administration on Wednesday defended its rejection of Moderna’s mRNA-based flu vaccine application, saying ...
The preservative is widely-used in food products such as breakfast cereals, cookies, candy, frozen meals and meat products.
WVNS Bluefield on MSN
FDA moves to stop non-approved GLP-1 drugs
WASHINGTON, D.C. (WVNS) – The U.S. Food and Drug Administration (FDA) plans to take steps to limit the use of GLP-1 in ...
The Food and Drug Administration on Tuesday took steps toward banning BHA, a food additive used in processed foods such as meats and bread ...
Here are some of the stocks making notable moves in Wednesday's premarket action: Moderna shares are sliding 9% after the Food and Drug Administration [refused to consider approving its new flu vaccin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results